Comparative effects of empagliflozin and metformin on metabolic dysfunction in polycystic ovary syndrome, a double blinded randomized control feasibility trial
gov/ registration date 11th of November 2023. Recruitment of the participants started at 15th of November 2023 and trial started in December 2023 and ended in June 2024.
Authors
- Hina Sharif (ORCID: https://orcid.org/0000-0002-4689-4703)
- Reeja Nasir (ORCID: https://orcid.org/0009-0000-4138-5718)
- Ammara Muzammil
- Naureen Rehman (ORCID: https://orcid.org/0009-0009-2070-8878)
- Sana Rehman (ORCID: https://orcid.org/0000-0001-8183-1778)
- Nadia Mohsin
- Wajiha Omair
- Sana Arsalan
- Farida Hatif
- Farah Wasti
Institutions
- Aga Khan University Hospital (PK)
- Planwel (PK)
- Bahria University (PK)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1186/s12905-025-04091-6
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.70